朱格隆的多向抗菌作用是针对Proteus mirabilis生物膜和毒性
Anaya Phatak1, Dinesh Rathod2, Kamlesh Patel3
1Department of Biotechnology, Savitribai Phule Pune University, Ganeshkhind, Pune 411007, Maharashtra, India.
Microbial pathogenesis
|February 8, 2026
概括
朱格隆是一种天然化合物,通过抑制生物膜形成和毒性,有效地对抗尿病原体Proteus mirabilis. 这种植物化学物质有望预防导管相关的尿路感染 (CAUTIs).
科学领域:
- 微生物学 微生物学
- 自然产品化学 自然产品化学
- 传染性疾病 传染性疾病
背景情况:
- 奇迹性蛋白质是导管相关的尿路感染 (CAUTIs) 的重要原因.
- 抗生素耐药性的增加需要新的抗菌战略.
- 植物化学品提供潜在的替代治疗对抗耐药性尿病原体.
研究的目的:
- 为了评估Juglone对Proteus mirabilis的抗菌膜和抗病毒效应.
- 阐明Juglone抗菌活性背后的机制.
- 探索Juglone在预防CAUTIs方面的潜力.
主要方法:
- 在体外检测细菌增殖,生物膜抑制和酶活性.
- FE-SEM用于生物膜可视化,运动性测试.
- 膜完整性和流动性的评估.
- 用RT-qPCR进行基因表达分析.
- 分子对接和动力学模拟.
- 没有针对性的LC-MS代谢.
主要成果:
- 朱格隆抑制了P.mirabilis的扩散,生物膜的形成,运动性和毒性因子的分泌.
- 观察到细菌包膜完整性受损,膜特性发生变化.
- 证实了粘附性和毒性基因的下调.
- 分子模拟表明与MrpH粘合物的稳定相互作用.
- 代谢分析显示了氧化应激,氧化还原失衡和抑制的代谢途径.
结论:
- 朱格隆对P.奇迹菌具有显著的抗菌膜和抗病毒性质.
- 它通过多种机制起作用,包括膜破坏和代谢重编程.
- 朱格隆是一种有前途的多目标药物,可以对抗P. mirabilis并预防CAUTIs.
相关概念视频
Targets for Drug Action: Overview
10.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K
Antimicrobial Effectiveness
1.0K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.0K
Fixed Action Patterns
17.7K
A fixed action pattern (FAP) is a specific, hard-wired sequence of behaviors that occurs in response to an external stimulus, called a sign stimulus. The behavior is “fixed” because it is essentially unchangeable—proceeding similarly across individuals of a species every time it occurs.
17.7K
Biofilms
1.4K
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
1.4K
Antimicrobial Proteins
14.5K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.5K
Action Potentials
142.9K
Overview
142.9K


